FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016364290> ?p ?o ?g. }

• W2016364290 endingPage "952" @default.
• W2016364290 startingPage "944" @default.
• W2016364290 abstract "Spinal fusion surgery in children and adolescents with idiopathic scoliosis is often associated with severe haemorrhage. Recombinant coagulation factor VIIa (rFVIIa) has previously been shown to be an effective haemostatic treatment for severe bleeding associated with a variety of coagulopathic and non-coagulopathic indications. The aim of this retrospective study was to assess the safety and haemostatic efficacy of rFVIIa in a series of 26 consecutive adolescent patients with scoliosis (22 females; mean age 16.6 years) undergoing correctional surgery. A second series of 26 consecutive patients (20 females; mean age 16.2 years) who received standard therapy during surgery, represented historical controls. Blood loss, transfusion requirements, duration of surgery, and peri-operative measurements of coagulation parameters were compared between the two groups. Intra-operative and combined intra-operative and post-operative blood losses were significantly smaller in the rFVIIa-treatment group than in the historical controls (P=0.003 and 0.032, respectively); rFVIIa-treated patients also demonstrated significantly reduced blood loss per vertebral segment fused (P=0.032) and per hour of surgery (P<0.001). Intra-operative requirements for packed red blood cells were also significantly lower in the treatment group (P=0.042). Patients in the treatment group demonstrated rapid and maintained reduction of prothrombin time and international normalised ratio; values among rFVIIa-treated patients remained significantly lower than those in the control group at all time points evaluated (P<0.001). There were no deaths and no adverse events. These results suggest that rFVIIa is a safe and effective haemostatic agent for use during spinal fusion surgery in adolescent patients with idiopathic scoliosis; however, further research and randomised, placebo-controlled trials are needed to confirm these findings." @default.
• W2016364290 created "2016-06-24" @default.
• W2016364290 creator A5008815370 @default.
• W2016364290 creator A5034161835 @default.
• W2016364290 creator A5046519449 @default.
• W2016364290 date "2005-08-17" @default.
• W2016364290 modified "2023-09-27" @default.
• W2016364290 title "Recombinant coagulation factor VIIa—a novel haemostatic agent in scoliosis surgery?" @default.
• W2016364290 cites W1574141134 @default.
• W2016364290 cites W1579955269 @default.
• W2016364290 cites W1846296988 @default.
• W2016364290 cites W1965179794 @default.
• W2016364290 cites W1975210832 @default.
• W2016364290 cites W1980080472 @default.
• W2016364290 cites W1989881520 @default.
• W2016364290 cites W1996136719 @default.
• W2016364290 cites W1996412465 @default.
• W2016364290 cites W1999014301 @default.
• W2016364290 cites W1999740505 @default.
• W2016364290 cites W2003783373 @default.
• W2016364290 cites W2010534123 @default.
• W2016364290 cites W2014312811 @default.
• W2016364290 cites W2016184368 @default.
• W2016364290 cites W2019483557 @default.
• W2016364290 cites W2022346832 @default.
• W2016364290 cites W2029804651 @default.
• W2016364290 cites W2032100111 @default.
• W2016364290 cites W2040538032 @default.
• W2016364290 cites W2043800309 @default.
• W2016364290 cites W2053569777 @default.
• W2016364290 cites W2058296078 @default.
• W2016364290 cites W2063038576 @default.
• W2016364290 cites W2065045390 @default.
• W2016364290 cites W2067324878 @default.
• W2016364290 cites W2070683120 @default.
• W2016364290 cites W2072719278 @default.
• W2016364290 cites W2073468975 @default.
• W2016364290 cites W2077936287 @default.
• W2016364290 cites W2082076083 @default.
• W2016364290 cites W2089507735 @default.
• W2016364290 cites W2092143682 @default.
• W2016364290 cites W2102246395 @default.
• W2016364290 cites W2108981885 @default.
• W2016364290 cites W2121451738 @default.
• W2016364290 cites W2158656134 @default.
• W2016364290 cites W2194834769 @default.
• W2016364290 cites W2266727270 @default.
• W2016364290 cites W2285001734 @default.
• W2016364290 cites W2322584072 @default.
• W2016364290 cites W2406500507 @default.
• W2016364290 cites W2433445627 @default.
• W2016364290 cites W2441104788 @default.
• W2016364290 cites W295478337 @default.
• W2016364290 cites W4238103798 @default.
• W2016364290 cites W74008669 @default.
• W2016364290 doi "https://doi.org/10.1007/s00586-005-1004-5" @default.
• W2016364290 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3489422" @default.
• W2016364290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16133083" @default.
• W2016364290 hasPublicationYear "2005" @default.
• W2016364290 type Work @default.
• W2016364290 sameAs 2016364290 @default.
• W2016364290 citedByCount "16" @default.
• W2016364290 countsByYear W20163642902014 @default.
• W2016364290 countsByYear W20163642902015 @default.
• W2016364290 countsByYear W20163642902019 @default.
• W2016364290 countsByYear W20163642902020 @default.
• W2016364290 crossrefType "journal-article" @default.
• W2016364290 hasAuthorship W2016364290A5008815370 @default.
• W2016364290 hasAuthorship W2016364290A5034161835 @default.
• W2016364290 hasAuthorship W2016364290A5046519449 @default.
• W2016364290 hasBestOaLocation W20163642902 @default.
• W2016364290 hasConcept C126322002 @default.
• W2016364290 hasConcept C12770488 @default.
• W2016364290 hasConcept C141071460 @default.
• W2016364290 hasConcept C197934379 @default.
• W2016364290 hasConcept C2778382381 @default.
• W2016364290 hasConcept C2778961111 @default.
• W2016364290 hasConcept C2779637338 @default.
• W2016364290 hasConcept C2780014101 @default.
• W2016364290 hasConcept C2780375110 @default.
• W2016364290 hasConcept C2780955175 @default.
• W2016364290 hasConcept C2991743468 @default.
• W2016364290 hasConcept C42219234 @default.
• W2016364290 hasConcept C71924100 @default.
• W2016364290 hasConceptScore W2016364290C126322002 @default.
• W2016364290 hasConceptScore W2016364290C12770488 @default.
• W2016364290 hasConceptScore W2016364290C141071460 @default.
• W2016364290 hasConceptScore W2016364290C197934379 @default.
• W2016364290 hasConceptScore W2016364290C2778382381 @default.
• W2016364290 hasConceptScore W2016364290C2778961111 @default.
• W2016364290 hasConceptScore W2016364290C2779637338 @default.
• W2016364290 hasConceptScore W2016364290C2780014101 @default.
• W2016364290 hasConceptScore W2016364290C2780375110 @default.
• W2016364290 hasConceptScore W2016364290C2780955175 @default.
• W2016364290 hasConceptScore W2016364290C2991743468 @default.
• W2016364290 hasConceptScore W2016364290C42219234 @default.
• W2016364290 hasConceptScore W2016364290C71924100 @default.
• W2016364290 hasIssue "6" @default.

• next